Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-033285

Chief Operations Officer sold 3,500 shares at $15.00 ($52,500)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Newell Joe Chief Operations Officer 2021-05-17 Sale −3,500 $15.00 $52,500 131,424 D
Open-market sales · 3,500 sh · avg $15.00 · $52,500
Loading xslF345X03/doc4.xml…